Sarah McBride / Bloomberg:
New York-based Synchron says it received FDA approval to test its brain-computer interface, beating Elon Musk’s Neuralink and others — A brain-computer interface company is entering clinical trials for its implants in the U.S., a big step toward getting the futuristic devices into more skulls to help treat conditions like paralysis.
